10-K: Concentra Reports Strong 2025 Growth, Strategic Acquisitions

Occupational health leader Concentra Group Holdings Parent, Inc. reports significant revenue and Adjusted EBITDA growth in its 2025 annual filing, driven by strategic acquisitions and organic expansion.

Summary

• Concentra Group Holdings Parent, Inc. (CON) is the largest provider of occupational health services in the U.S., operating 628 stand-alone occupational health centers in 41 states and 411 onsite health clinics in 44 states as of December 31, 2025.
• Revenue for the year ended December 31, 2025, increased by 13.9% to $2,163.4 million, up from $1,900.2 million in 2024.
• Adjusted EBITDA grew by 14.6% to $431.9 million in 2025, compared to $376.9 million in 2024, with Adjusted EBITDA margin at 20.0%.
• Net income attributable to the Company was $166.4 million in 2025, a slight decrease from $166.5 million in 2024, while Adjusted Net Income Attributable to the Company increased to $176.0 million from $168.5 million.
• Total patient visits increased by 7.3% to 13.5 million in 2025, with Workers Compensation visits up 7.3% and Employer Services visits up 7.7%.
• The company completed two significant acquisitions in 2025: Nova Medical Centers for $265.0 million (adding 67 occupational health centers) and Pivot Onsite Innovations for $54.4 million (adding over 240 onsite health clinics).
• Voluntary repayments of $85.0 million were made on the Revolving Credit Facility, resulting in no outstanding borrowings as of December 31, 2025.
• A share repurchase program was authorized on November 5, 2025, for up to $100 million of common stock, with $20.0 million repurchased in 2025, leaving $80.0 million authorized.
• Quarterly cash dividends of $0.0625 per share were declared and paid throughout 2025, totaling $32.1 million.
• The company's stock performance from July 25, 2024, to December 31, 2025, showed a decline of 11.14%, underperforming the S&P 500 (+26.79%) and S&P Health Care Services Select Industry Index (+10.42%).
• The company is subject to several legal proceedings, including investigations by the DOJ and California Department of Insurance related to physical therapy billing, and class action lawsuits stemming from a third-party data breach (PJ&A).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive, reflecting strong operational growth and strategic expansion through acquisitions, alongside proactive debt management and shareholder returns. However, significant legal challenges and underperforming stock price temper the overall sentiment.

Positives

• Revenue increased by 13.9% to $2,163.4 million in 2025, demonstrating strong top-line growth.
• Adjusted EBITDA grew by 14.6% to $431.9 million in 2025, indicating improved operational profitability.
• Successful strategic acquisitions of Nova Medical Centers ($265.0 million) and Pivot Onsite Innovations ($54.4 million) significantly expanded the company's footprint by 67 occupational health centers and over 240 onsite health clinics.
• Voluntary repayment of $85.0 million on the Revolving Credit Facility, reducing outstanding debt and demonstrating strong cash flow management.
• Authorization of a $100 million share repurchase program, with $20.0 million already executed, signaling confidence in valuation and commitment to shareholder returns.
• Total patient visits increased by 7.3% to 13.5 million in 2025, reflecting strong demand for services.
• Maintained strong relationships with approximately 200,000 employers, including 100% of Fortune 100 companies, with 98% of top 100 customers having been clients for at least ten years.
• Reported lower average total claim costs (25% lower) and shorter average claim duration (65 fewer days) compared to non-Concentra claims, highlighting high-quality care and clinical outcomes.
• High patient satisfaction, with 79% of patients rating overall satisfaction at 9 or 10 out of 10 over the last three years.
• Effective internal control over financial reporting as of December 31, 2025, as assessed by management and audited by PricewaterhouseCoopers LLP.

Negatives

• Net income attributable to the Company slightly decreased to $166.4 million in 2025 from $166.5 million in 2024, despite significant revenue growth.
• Interest expense increased substantially to $109.3 million in 2025 from $47.7 million in 2024, primarily due to new debt financing.
• General and administrative expense increased to $203.3 million (9.4% of revenue) in 2025 from $156.3 million (8.2% of revenue) in 2024, driven by acquisition and separation costs, stock compensation, and new personnel costs.
• The company's common stock price declined by 11.14% from its NYSE debut on July 25, 2024, to December 31, 2025, significantly underperforming broader market indices.
• Ongoing legal investigations by the DOJ and California Department of Insurance related to physical therapy billing practices pose potential liabilities and reputational risks.
• Subject to multiple class action lawsuits related to the Perry Johnson & Associates, Inc. (PJ&A) data breach, which could result in significant costs and reputational harm.
• The nature of the markets served may constrain the ability to realize reimbursement increases sufficient to keep pace with cost inflation, particularly for workers compensation services.
• Labor shortages, increased employee turnover, and rising employee-related costs could significantly increase operating costs and reduce profitability.

Risks

• A decline in the frequency of work-related injuries and illnesses, or a shift in employment trends to less injury-prone industries, could negatively affect business, financial condition, and results of operations.
• Adverse changes to relationships with significant employer customers, third-party payors, or provider networks could adversely affect revenue and profitability.
• Operating in a heavily regulated industry means changes to regulations, new interpretations, or violations could result in increased costs or sanctions.
• Cost containment initiatives or state fee schedule changes by workers compensation boards and other third-party payors may adversely affect revenue, profitability, and financial condition.
• Inability to realize reimbursement increases at rates sufficient to keep pace with the inflation of operating costs could lower margins.
• Labor shortages, increased employee turnover, rising employee-related costs, and union activity could significantly increase operating costs and reduce profitability.
• Failure to compete effectively with other occupational health centers, onsite health clinics, and healthcare providers could lead to declining revenue and profitability.
• Security breaches, cyberattacks, loss of data, or cybersecurity incidents involving the company's or third-party vendors' IT systems could compromise confidential data, harm patients, and result in legal and reputational damage.
• Negative publicity can lead to increased governmental and regulatory scrutiny and potentially adverse regulatory changes.
• Significant legal actions, including professional liability claims and whistleblower lawsuits, could subject the company to substantial uninsured liabilities.
• Current and future acquisitions may use significant resources, be unsuccessful, or expose the company to unforeseen liabilities, and integration difficulties could divert management attention.
• Reliance on third parties in many aspects of the business exposes the company to additional risks if these partners fail to meet obligations or comply with standards.
• Compliance with applicable laws regarding the corporate practice of medicine and therapy and professional fee-splitting is complex and subject to evolving interpretations, potentially requiring structural modifications.
• Dependence on relationships with affiliated professional entities (Managed PCs) that the company does not own, and potential harm if these relationships are disrupted or challenged.
• Extensive federal and state laws and regulations relating to data privacy and security (e.g., HIPAA, TCPA, CAN-SPAM), with any failure to comply potentially leading to significant penalties and reputational harm.
• Facility licensure requirements in some states are costly and time-consuming, and failure to comply could result in fines, penalties, or operational delays/closures.
• Inability to maintain, protect, or enforce intellectual property rights could harm competitive advantage and business.
• Claims of infringement upon third-party intellectual property rights could lead to substantial defense costs, monetary damages, or rebranding requirements.
• Changes and uncertainty in the healthcare industry, including public policy developments and new laws (e.g., No Surprises Act, OBBBA), could adversely impact the business.
• Adverse economic conditions, including workforce reductions, decreased healthcare spending, and inflation, could negatively affect financial performance.
• Geopolitical instability and global conflicts could adversely affect the global economy, capital markets, supply chains, and the company's ability to access capital.
• Impairment of goodwill and other intangible assets would result in a reduction in net income.
• Substantial indebtedness ($1,574.4 million as of December 31, 2025) limits cash flow for investments and increases vulnerability to adverse conditions and interest rate increases.
• Credit Facilities require compliance with covenants, and default could result in acceleration of debt.
• Limited history of operating as a standalone public company, with historical financial information potentially not fully reflecting future results.
• May not achieve all expected benefits of the Separation from Select, and the Separation could adversely affect the business.
• Potential indemnification obligations to Select Medical Corporation (SMC) in connection with the Separation could result in substantial liabilities.
• Reliance on SMC for transitional services, with risks if SMC fails to perform or if replacement systems are not in place upon expiration of the Transition Services Agreement.
• Joint and several liability with Select for consolidated U.S. federal income taxes for periods prior to the Distribution.
• May have received less favorable terms from Select and SMC in separation agreements compared to arms-length negotiations.
• Stock price volatility and potential for significant fluctuations.
• Potential dilution of percentage ownership from future issuance of common stock or convertible debt securities.
• As a holding company, dependence on subsidiaries' ability to pay dividends and make other payments.
• No guarantee of future dividend payments, and ability to pay dividends is subject to discretion of the Board and debt covenants.
• If estimates or judgments relating to critical accounting policies prove incorrect, results of operations could be adversely affected.
• Certain provisions in the amended and restated certificate of incorporation and bylaws, and Delaware law, may prevent or delay an acquisition.
• Public health threats, such as pandemics, may create uncertainties about future operating results and financial conditions.
• Loss of key members of the management team could significantly disrupt business operations.
• Ability to attract and retain talented, highly skilled employees and a diverse workforce, and effective succession planning, are crucial for long-term success.
• Climate change, or legal, regulatory, or market measures to address it, could adversely affect the business.
• Increasing scrutiny and rapidly evolving expectations from stakeholders regarding ESG matters could adversely affect the business.
• Changes in tax laws or exposures to additional tax liabilities could negatively impact the effective tax rate and financial results.

Future Outlook

The company plans to drive organic growth by capturing market share through customer acquisition and retention, leveraging its trusted brand and high visibility. Strategic acquisitions and building new de novo centers remain a key part of the growth strategy, with a focus on expanding the occupational health center footprint and onsite health clinics. Service offerings will continue to expand, including advanced primary care and workers compensation behavioral health services via telemedicine. The company also intends to invest in adjacent business areas and geographies, such as workplace safety and specialty care, to diversify offerings and broaden market opportunity. However, the company acknowledges that the healthcare industry is subject to changing political, regulatory, and economic influences, and the ultimate effect of new legislation like the OBBBA is difficult to predict.

Management Comments

• Our mission is to improve the health of America's workforce.
• We believe our success is measured by the quality of care we provide at our occupational health centers.
• Our average total claim costs were 25% lower and average claim duration was 65 fewer days per claim when compared to non-Concentra claims, based on claim studies from 2020 to 2025.
• Approximately 95% of injured employees seen by us after their initial visit were recommended to return to work in some capacity on the same day in 2025, which we believe results in more productive employees for our customers.
• Technology continues to be at the forefront of our strategic vision, and we continue to make advancements by introducing key technologies that focus on delivering an exceptional colleague and customer experience.
• We believe we are well positioned to acquire businesses in areas which are adjacent and complementary to our current occupational health services offering and will be aligned with our mission and business goals.

Industry Context

StockSavvy.ai notes that Concentra operates within a growing U.S. occupational health services market, driven by a large and aging workforce, increasing claims involving comorbidities, reshoring of manufacturing, and higher injury rates among less experienced employees. The industry is also seeing a demand for more cost-effective healthcare solutions and faces challenges in conventional urgent care due to labor costs. Concentra's expansion into advanced primary care and workers compensation behavioral health services via telemedicine aligns with broader industry trends seeking holistic and accessible care. The competitive landscape remains highly fragmented, with competition from independent practices, regional groups (e.g., MBI Industrial Medicine, Akeso Occupational Health), hospital-owned clinics (e.g., Kaiser Permanente, Banner Health), and consumer-focused urgent care providers (e.g., American Family Care Urgent Care, CareNow Urgent Care). The increasing acceptance of telemedicine is reducing geographic barriers for competitors.

Comparison to Industry Standards

• The company's claim studies from 2020 to 2025 indicate average total claim costs were 25% lower and average claim duration was 65 fewer days per claim when compared to non-Concentra claims, suggesting superior efficiency and outcomes in workers' compensation management.
• In 2025, approximately 95% of injured employees seen by the company after their initial visit were recommended to return to work in some capacity on the same day, which is a strong indicator of effective injury management and rapid return-to-work protocols compared to general industry averages.
• Patient satisfaction is high, with 79% of patients rating overall satisfaction at 9 or 10 on a scale of 1-10 over the last three years, which compares favorably to typical healthcare industry benchmarks for patient experience.
• The company's expansion to over 400 onsite health clinics at employer worksites positions it competitively against national players like Premise Health and Marathon Health, which also focus on onsite primary care and occupational health services.
• In the fragmented occupational health market, Concentra's scale with 628 stand-alone centers and 411 onsite clinics provides a significant competitive advantage over smaller independent practices (1-3 locations) and regional groups (10-50 locations) like MBI Industrial Medicine and Akeso Occupational Health/Agile Occupational Medicine.

Management Changes

Corporate Governance

Legal Proceedings

• A qui tam lawsuit under the California Insurance Fraud Prevention Act (CIFPA) was unsealed on November 10, 2025, alleging the company submitted false and fraudulent claims for physical therapy reimbursement and retaliated against the relator.
• Received a subpoena from the California Department of Insurance on February 5, 2024, relating to an investigation under the CIFPA concerning billing and coding for physical therapy claims submitted to commercial insurers and workers compensation carriers.
• Subject to six putative class action lawsuits (consolidated in U.S. District Court for the Eastern District of New York) related to the Perry Johnson & Associates, Inc. (PJ&A) data breach, alleging negligence, breach of contract, and failure to comply with statutory duties.
• Under investigation by the U.S. Department of Justice (DOJ) since 2021, in conjunction with HHS, for potential False Claims Act violations related to physical therapy billing, with a related qui tam lawsuit unsealed in May 2024 (not naming Concentra as a defendant).

Related Party Transactions

• The company continues to have material agreements with Select Medical Corporation (SMC) following its spin-off, including a separation agreement, a transition services agreement, a tax matters agreement, and an employee matters agreement.
• Transition services agreement fees paid to Select were $12.1 million for the year ended December 31, 2025.
• The company has joint and several liability with Select for the consolidated U.S. federal income taxes of the Select consolidated group for taxable periods in which it was part of the group.

Stakeholder Impact

• Shareholders: Impacted by the share repurchase program, quarterly dividends, and the volatility of the common stock price, which underperformed market indices. Legal proceedings and debt levels also pose risks to shareholder value.
• Employees: Affected by talent acquisition and retention efforts, training and development programs, competitive compensation and benefits, and employee engagement initiatives. Cybersecurity incidents could impact employee data and morale.
• Customers: Benefit from expanded service offerings and geographic reach through acquisitions, high-quality care, and operational excellence. Cybersecurity breaches could erode trust and impact service delivery.
• Payors (insurance carriers, third-party administrators): Relationships are crucial for revenue generation, but cost containment initiatives and regulatory audits can create disputes and affect reimbursement.
• Creditors: Impacted by the company's substantial indebtedness and compliance with debt covenants. Strong operational cash flow and voluntary debt repayments are positive for creditors.

Next Steps

• Continue driving organic growth through customer acquisition and retention.
• Execute strategic acquisitions of existing occupational health centers and building new de novo centers.
• Expand service offerings, including advanced primary care and workers compensation behavioral health services via telemedicine.
• Invest in adjacent business areas and geographies, such as workplace safety and specialty care.
• Refinance long-term indebtedness before it matures.
• The Board of Directors will consider future cash dividends, subject to financial condition and debt covenants.
• File the definitive proxy statement relating to the annual meeting of shareholders on or about April 30, 2026.

Key Dates

Recommendation

Concentra demonstrates strong operational growth, evidenced by significant increases in revenue and Adjusted EBITDA, and has strategically expanded its footprint through key acquisitions. The company's proactive debt management and initiation of a share repurchase program are positive signals. However, the slight dip in net income attributable to the company, substantial increase in interest expense, and ongoing legal and regulatory investigations, particularly concerning billing practices and data security, introduce considerable uncertainty. The stock's underperformance since its IPO suggests the market is already pricing in some of these concerns. A 'hold' recommendation is appropriate as the company navigates these challenges, with potential for upside if legal risks are mitigated and integration synergies are fully realized, but also downside risk from adverse legal outcomes or economic headwinds.

Keywords

Occupational Health Services, Workers Compensation, Onsite Health Clinics, Telemedicine, Healthcare Acquisitions, Debt Financing, Share Repurchase Program, Financial Performance, SEC Filing, 10-K, Corporate Governance, Risk Management, Healthcare Regulation, Cybersecurity, Patient Care, Employer Services, CON